Dr. László Tabár

Breast
Mammography's alleged harms: Separating fact from fiction
Screening mammography is a tool that has been proved to reduce breast cancer death rates, but its effectiveness continues to be disputed by researchers, some of whom have resorted to guesswork to buttress their arguments, according to an opinion piece by mammography experts Dr. László Tabár and Dr. Peter B. Dean.
December 12, 2012
2012 12 12 12 51 12 319 Tabar Lazslo Thumb
Breast
Analysis of Swedish county data is off the mark
In this week's study in the Journal of the National Cancer Institute, a research team claimed to find that mammography screening had no impact on mortality from breast cancer, based on their interpretation of data from Swedish counties. However, the group made a number of fatal mistakes in their analysis, according to Dr. László Tabár.
July 16, 2012
2009 06 23 14 37 33 976 Second Opinion Am
Page 1 of 1
Top Stories
Dexa
Digital X-Ray
3D DEXA shows value in patients with prostate cancer
3D DEXA may be a practical and valuable tool for detecting structural bone changes in prostate cancer patients.
Rebecca Smith-Bindman, MD
CT
Smith-Bindman unpacks NEJM pediatric CT study
Mammography Breast Ipad Patient 400
Womens Imaging
Women who skip first mammogram more likely to die of breast cancer
Breast Tomosynthesis Digital 400 (1)
AI
Study finds AI not cost-effective for breast cancer screening
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Home
3D DEXA shows value in patients with prostate cancer
By Will Morton
3D DEXA may be a practical and valuable tool for detecting structural bone changes in prostate cancer patients.
September 25, 2025
Dexa
Smith-Bindman unpacks NEJM pediatric CT study
By Kate Madden Yee
In a video interview, the researcher acknowledged CT's importance to patient care but advocated for its appropriate use.
September 25, 2025
Rebecca Smith-Bindman, MD
Women who skip first mammogram more likely to die of breast cancer
By Amerigo Allegretto
Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.
September 24, 2025
Mammography Breast Ipad Patient 400
Study finds AI not cost-effective for breast cancer screening
By Amerigo Allegretto
AI is not cost-effective for breast cancer screening, even with reductions in mortality, false-positive cases, and false-negative cases, according to new research.
September 24, 2025
Breast Tomosynthesis Digital 400 (1)
ACS: Cancer survival rates are lower in rural areas
By Kate Madden Yee
The research also reported lower cancer survival rates for Blacks compared to whites, underscoring "disparities in receipt of care."
September 24, 2025
Rural Res
Save power, curb carbon by switching off surplus CT scanners
By Kate Madden Yee
A new study's findings suggest a relatively easy way to "go green" in the radiology suite.
September 23, 2025
Planet Sustainability
Radiologists deem AI x-ray reports clinically acceptable
By Will Morton
There was no evidence of a difference in acceptability between AI- and radiologist-generated reports under a standard criterion.
September 23, 2025
Kara Cxr
ACR CEO talks imaging’s role in spending bill
By Amerigo Allegretto
Dana Smetherman, MD, CEO of the ACR, spoke with AuntMinnie.com about appropriations bills and how imaging may be affected.
September 23, 2025
American Flag Waving 400 (1)
Adding MBI to DBT finds more breast cancers
By Amerigo Allegretto
Adding molecular breast imaging (MBI) to DBT screening leads to more invasive cancers detected in women with dense breasts.
September 23, 2025
Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).
DEXA study questions OsteoStrong claims
By Will Morton
Bone outcomes either remained stable or declined in 38 women who used the musculoskeletal strengthening program for eight months.
September 22, 2025
Dexa
MWA successful in treating multinodal thyroid conditions
By Amerigo Allegretto
Ultrasound-guided MWA is effective for treating solitary nodules, multinodular goiters, and autonomously functioning nodules.
September 22, 2025
Ultrasound Collage
AI industry paid $39.7M for radiology devices between 2017 and 2023
By Will Morton
The funds were part of a total of $179 million in payouts to healthcare professionals and hospitals over the timeframe.
September 22, 2025
Ai Money
Page 1 of 172
Next Page